Moderna Ousts New Finance Chief Amid Probe at Dentsply
11 Mai 2022 - 2:59PM
Dow Jones News
By Colin Kellaher
Moderna Inc. on Wednesday said Jorge Gomez, who joined the
vaccine maker this week as chief financial officer, has left amid
an investigation by his former employer, Dentsply Sirona Inc., into
matters that include financial reporting.
Moderna said David Meline, who had retired as chief financial
officer, will retake the post while the company reopens its search
for a successor.
Dentsply on Tuesday said its board's audit committee is looking
into the use of incentives to sell products to distributors last
year and whether the incentives were appropriately accounted for
and the effect of the sales adequately disclosed.
The Charlotte, N.C., maker of dental products and technologies
also said it is investigating allegations that certain current and
former members of senior management directed the use of the
incentives and other actions to hit executive compensation targets
last year.
Dentsply last month abruptly fired Don Casey as chief executive
and removed him from the board.
Mr. Gomez, meanwhile, resigned as Dentsply's chief financial
officer to take the same post at Moderna and joined the Cambridge,
Mass., company on Monday.
Moderna on Wednesday said that despite being on the job for just
days, Mr. Gomez will receive a year's pay of $700,000 as part of
his severance package. Mr. Gomez will forfeit his $500,000 signing
bonus and other bonus eligibility, the company said.
Write to Colin Kellaher at colin.kellaher@wsj.com
(END) Dow Jones Newswires
May 11, 2022 08:44 ET (12:44 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
DENTSPLY SIRONA (NASDAQ:XRAY)
Historical Stock Chart
Von Mär 2024 bis Apr 2024
DENTSPLY SIRONA (NASDAQ:XRAY)
Historical Stock Chart
Von Apr 2023 bis Apr 2024